why choose us

First received: August 01, 2022

Clinical Trial: Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: Endoscopic Gastric Mucosal Ablation (GMA) as a Primary Obesity Therapy Early Feasibility [COMET EF] - Step II

Brief Summary: This study is intended to investigate safety and feasibility of a new weight loss technique called endoscopic Gastric Mucosal Ablation (GMA) that does not require surgery, but can be achieved using an endoscopic procedure.Previous studies have suggested that weight loss after vertical sleeve gastrectomy (VSG) is partly due to the removal of normal stomach tissue suspected of having hormonal function.The study will investigate the minimally invasive treatment of obesity by means of argon plasma coagulation (APC) in…

Read more